Ovarian Cancer
Hypochlorous acid enhances immunogenicity of allogeneic ovarian tumor cells
Published in Vaccine Weekly, October 4th, 2006
According to recent research from England, "Ovarian cancer commonly relapses after remission and new strategies to target microscopic residual diseases are required. One approach is to activate tumor-specific cytotoxic T cells with dendritic cells loaded with tumor cells."
"In order to enhance their immunogenicity, ovarian tumor cells (SKOV3, which express two well-characterized antigens HER-2/neu and MUC-1) were killed by oxidation with hypochlorous acid (HOCl). Treatment for one hour with 60 micromolar...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-10-04)
More Articles from Vaccine Weekly
- Meningitis Vaccine
Haemophilus influenzae type b experience in Alaska is reported - Rotavirus Vaccine
Bovine-human rotavirus reassortant tetravalent vaccine safe and immunogenetic - SARS Vaccine
Long-lived memory T cell responses to SARS antigen in recovered SARS patients are described - Vaccine Development
Cell-surface display technology in yeast prepares the source of an oral vaccine - Apoptosis
Neurotrophic factors protect TNF-related apoptosis-inducing ligand-mediated apoptosis - Avian Influenza
BioDiem and Nobilon join top U.S. science facility in race to develop bird flu vaccine - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
